The impact of amino acid variability on alloreactivity defines a functional distance predictive of permissive HLA-DPB1 mismatches in hematopoietic stem cell transplantation.

A major challenge in unrelated hematopoietic stem cell transplantation (HSCT) is the prediction of permissive HLA mismatches, ie, those associated with lower clinical risks compared to their nonpermissive counterparts. For HLA-DPB1, a clinically prognostic model has been shown to be matching for T cell epitope (TCE) groups assigned by cross reactivity of T cells alloreactive to HLA-DPB1∗09:01; however, the molecular basis of this observation is not fully understood. Here, we have mutated amino acids (aa) in 10 positions of HLA-DPB1∗09:01 to other naturally occurring variants, expressed them by lentiviral vectors in B cell lines, and quantitatively measured allorecognition by 17 CD4(+) T cell effectors from 6 unrelated individuals. A significant impact on the median alloresponse was observed for peptide contact positions 9, 11, 35, 55, 69, 76, and 84, but not for positions 8, 56, and 57 pointing away from the groove. A score for the "functional distance" (FD) from HLA-DPB1∗09:01 was defined as the sum of the median impact of polymorphic aa in a given HLA-DPB1 allele on T cell alloreactivity. Established TCE group assignment of 23 alleles correlated with FD scores of ≤0.5, 0.6 to 1.9 and ≥2 for TCE groups 1, 2, and 3, respectively. Based on this, prediction of TCE group assignment will be possible for any given HLA-DPB1 allele, including currently 367 alleles encoding distinct proteins for which T cell cross reactivity patterns are unknown. Experimental confirmation of the in silico TCE group classification was successfully performed for 7 of 7 of these alleles. Our findings have practical implications for the applicability of TCE group matching in unrelated HSCT and provide new insights into the molecular mechanisms underlying this model. The innovative concept of FD opens new potential avenues for risk prediction in unrelated HSCT.

[1]  Harriet Noreen,et al.  High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. , 2007, Blood.

[2]  M. Aljurf,et al.  Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation. , 2014, Blood.

[3]  D. Blaise,et al.  HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[4]  M. Amicosante,et al.  Detailed analysis of the effects of Glu/Lys beta69 human leukocyte antigen-DP polymorphism on peptide-binding specificity. , 2003, Tissue antigens.

[5]  J. Falkenburg,et al.  Patient HLA-DP-specific CD4+ T cells from HLA-DPB1-mismatched donor lymphocyte infusion can induce graft-versus-leukemia reactivity in the presence or absence of graft-versus-host disease. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[6]  Katharina Fleischhauer,et al.  Frequency and targeted detection of HLA-DPB1 T cell epitope disparities relevant in unrelated hematopoietic stem cell transplantation. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  E Lanino,et al.  Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain. , 2001, Blood.

[8]  Barbara Bruno,et al.  Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation. , 2009, Blood.

[9]  D. Miklos,et al.  Risk-associations between HLA-DPB1 T cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent from HLA-DPA1 , 2014, Bone Marrow Transplantation.

[10]  M. Amicosante,et al.  Functional analysis of HLA-DP polymorphism: a crucial role for DPbeta residues 9, 11, 35, 55, 56, 69 and 84-87 in T cell allorecognition and peptide binding. , 2003, International immunology.

[11]  P. Greenberg,et al.  Use of CD137 to study the full repertoire of CD8+ T cells without the need to know epitope specificities , 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[12]  A. Gratwohl,et al.  Impact of HLA-DPB1 haplotypes on outcome of 10/10 matched unrelated hematopoietic stem cell donor transplants depends on MHC-linked microsatellite polymorphisms. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[13]  M. Betjes,et al.  Activation‐induced CD137 is a fast assay for identification and multi‐parameter flow cytometric analysis of alloreactive T cells , 2013, Clinical and experimental immunology.

[14]  J. Madrigal,et al.  Translating the HLA-DPB1 T-cell epitope-matching algorithm into clinical practice , 2013, Bone Marrow Transplantation.

[15]  L. Naldini,et al.  Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters , 2005, Nature Biotechnology.

[16]  Tao Wang,et al.  Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders. , 2012, Blood.

[17]  C. Nombela,et al.  HLA-DPbeta residue 69 plays a crucial role in allorecognition. , 1998, Tissue Antigens.

[18]  Douglas G. Mack,et al.  Crystal structure of HLA-DP2 and implications for chronic beryllium disease , 2010, Proceedings of the National Academy of Sciences.

[19]  C. Bordignon,et al.  Peripheral blood stem cell allograft rejection mediated by CD4+ T lymphocytes recognizing a single mismatch at HLA-DPβ1*0901 , 2001 .

[20]  A. Bacigalupo A closer look at permissive HLA mismatch. , 2013, Blood.

[21]  Xu Liu,et al.  Development and Validation of a Gamma Interferon ELISPOT Assay for Quantitation of Cellular Immune Responses to Varicella-Zoster Virus , 2001, Clinical Diagnostic Laboratory Immunology.

[22]  J. Kuball,et al.  Refinement of the definition of permissible HLA-DPB1 mismatches with predicted indirectly recognizable HLA-DPB1 epitopes. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[23]  J. Madrigal,et al.  The impact of HLA genotyping on survival following unrelated donor haematopoietic stem cell transplantation , 2010, British journal of haematology.

[24]  F. Sizzano,et al.  Significantly higher frequencies of alloreactive CD4+ T cells responding to nonpermissive than to permissive HLA-DPB1 T-cell epitope disparities. , 2010, Blood.

[25]  M. Tilanus,et al.  Effects of transmembrane region variability on cell surface expression and allorecognition of HLA-DP3. , 2013, Human immunology.

[26]  Anajane G. Smith,et al.  The biological significance of HLA‐DP gene variation in haematopoietic cell transplantation , 2001, British journal of haematology.

[27]  H. Inoko,et al.  Cloned primed lymphocyte test cells recognize the fourth, fifth, and sixth hypervariable regions at amino acid positions 65-87 of the DPB1 molecule. , 1995, Human immunology.

[28]  C. Bordignon,et al.  Peripheral blood stem cell allograft rejection mediated by CD4(+) T lymphocytes recognizing a single mismatch at HLA-DP beta 1*0901. , 2001, Blood.

[29]  Maria Pia Sormani,et al.  A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. , 2003, Blood.

[30]  Medhat Askar,et al.  Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation. , 2014, Blood.

[31]  M. Schell,et al.  Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization , 2013, Bone Marrow Transplantation.

[32]  J. Wagner,et al.  Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. , 2010, The Lancet. Oncology.

[33]  Loren Gragert,et al.  HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry. , 2014, The New England journal of medicine.

[34]  E. Petersdorf Optimal HLA matching in hematopoietic cell transplantation. , 2008, Current opinion in immunology.

[35]  J. Pidala,et al.  Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality. , 2013, Blood.

[36]  C. Nombela,et al.  HLA-DPp residue 69 plays a crucial role in allorecognition , 1998 .

[37]  L. Zhao,et al.  Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT. , 2012, Blood.

[38]  Lili Wang,et al.  Formalization of the MESF unit of fluorescence intensity , 2004, Cytometry. Part B, Clinical cytometry.

[39]  Brent R Logan,et al.  A perspective on the selection of unrelated donors and cord blood units for transplantation. , 2012, Blood.

[40]  H. Bickeböller,et al.  Impact of HLA‐DPB1 allelic and single amino acid mismatches on HSCT , 2008, British journal of haematology.

[41]  C. Carcassi,et al.  Graft rejection after unrelated donor hematopoietic stem cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-versus-graft direction. , 2006, Blood.

[42]  Effie W Petersdorf,et al.  Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study. , 2012, The Lancet. Oncology.